Other conditions Board decisions

The Veteran's adult son, who was rendered incapable of self-support prior to the age of 18 due to his disabilities, is recognized as a helpless child for purposes of entitlement to Dependency and Indemnity Compensation (DIC) benefits.

The Board has granted payment or reimbursement of expenses incurred in connection with the ambulance transportation service provided on November 13, 2019, due to emergency medical needs at a non-VA facility. The Veteran's condition was not related to his military service.

The Board has decided to remand the case due to unclear information regarding whether or not the claim for payment of non-VA medical services provided from February 27, 2019 to March 1, 2019 was resubmitted and paid in full. The decision will include a summary of applicable laws and regulations, identification of findings favorable to the claimant, and whether or not the claim meets each of the criteria necessary for payment under VA policy.

The Veteran's claim for an automobile and adaptive equipment was dismissed as it is not a claim for 'periodic monetary benefits' due to his death, which extinguished the claim.

The Veteran's claim for reimbursement of prescription medications was denied because the treatment did not meet the eligibility criteria under 38 U.S.C. § 1725, as there was no evidence of emergency medical treatment in a VA or non-VA facility.

The Board has decided to remand the case due to incomplete records and inadequate medical opinions. The Veteran's left hip disability is related to his service-connected back disability, but the extent of this relationship needs further clarification.

The Board has determined that the Veteran's basal cell carcinoma is causally related to his in-service exposure to ionizing radiation, and thus service connection for this condition is granted.

The Veteran's cause of death, hepatocellular cancer, is related to his service-connected exposure to Agent Orange.,The Appellant's income exceeds the maximum annual pension rate for a surviving spouse without dependents.

The Board has decided that the Veteran does not meet the eligibility requirements for PCAFC benefits due to a lack of personal care services and needs supervision or protection based on symptoms or residuals of neurological or other impairment. The decision is remanded as there are legal issues with the medical opinion provided by the CEAT.

The Veteran's tongue and throat cancer is presumed due to his service in Vietnam, but a VA examination is needed to determine if it is related to this exposure.

The appeal seeking payment or reimbursement for the cost of medical services performed on December 4, 2019 by Aegis Sciences Corporation is dismissed.

The Board has remanded the Veteran's claims for Kallmann syndrome and a right hand and finger disability due to inadequate medical opinions and failure to provide necessary examinations.

The Veteran withdrew her appeal regarding the withholding of disability compensation benefits for recoupment of severance pay in the amount of $9,360.

The Veteran's appeal was denied as the ambulance services provided did not involve transportation to an emergency facility, and therefore, VA payment or reimbursement is not allowed.

The Board has granted the Veteran's claim for service connection for cerebrovascular disease, unspecified as secondary to his service-connected Parkinson's disease.

Your appeal has been dismissed because the Veteran died during the pendency of your case. The Board does not have jurisdiction to decide the merits of this claim.

The appeal was dismissed because the appellant requested to withdraw their appeal before a decision could be made.

The appeal of the non-VA medical expenses claim is dismissed as there was no VA determination to appeal.

The appeal of the non-VA medical expenses claim is dismissed because VA did not make a determination denying the benefits sought.

The Board has granted the Veteran's claim for payment or reimbursement of expenses incurred in connection with Mayo Clinic ambulance transportation service on November 13, 2019. The decision is based on the fact that the treatment was emergent and non-service-connected.